Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Dengue viruses are widespread in most tropical and subtropical regions of the world. This study will evaluate the safety and protective efficacy of a dengue vaccine (called TV005) against viremia and rash induced by a DENV-2 vaccine virus (called rDEN2∆30-7169) in healthy adults.
Epistemonikos ID: c6d84ac85727ed0a9b33a441f9a03d74acf28d06
First added on: May 12, 2024